https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.776807/full
https://pubmed.ncbi.nlm.nih.gov/33704555/
https://pmc.ncbi.nlm.nih.gov/articles/PMC8826242/
https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2024.1410133/full
https://pmc.ncbi.nlm.nih.gov/articles/PMC11466766/
https://pmc.ncbi.nlm.nih.gov/articles/PMC10451954/
https://medlineplus.gov/genetics/condition/primary-coenzyme-q10-deficiency/
https://www.ncbi.nlm.nih.gov/books/NBK410087/
https://pubmed.ncbi.nlm.nih.gov/32743982/
https://www.pharmacytimes.com/view/fda-grants-rare-pediatric-disease-designation-to-bpm31510iv-for-primary-coq10-deficiency
https://bpgbio.com/bpgbio-receives-fda-rare-pediatric-disease-designation-for-its-potential-treatment-for-primary-coenzyme-q10-deficiency/
https://www.businesswire.com/news/home/20240930208348/en/BPGbio-Receives-FDA-Rare-Pediatric-Disease-Designation-for-its-Potential-Treatment-for-Primary-Coenzyme-Q10-Deficiency
https://finance.yahoo.com/news/bpgbio-receives-fda-rare-pediatric-110000218.html
https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/
https://checkrare.com/2024-orphan-drugs-pdufa-dates-and-fda-approvals-2/
https://www.businesswire.com/news/home/20241023308697/en/BPGbio-to-Present-New-Data-on-BPM31510-and-Novel-Quinomics-Technology-for-Treatment-of-Primary-CoQ10-Deficiency-at-MitoCon-2024
https://www.ddw-online.com/three-drugs-secure-rare-paediatric-disease-designation-in-the-us-31790-202410/
https://www.globenewswire.com/news-release/2025/06/18/3101316/0/en/BPGbio-Announces-Presentation-of-Preliminary-Clinical-Data-of-Investigational-BPM31510-for-Primary-CoQ10-Deficiency.html
https://bpgbio.com/bpgbio-to-present-new-data-on-bpm31510-and-novel-quinomics-technology-for-treatment-of-primary-coq10-deficiency-at-mitocon-2024/


https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011897
https://www.mayoclinic.org/drugs-supplements-coenzyme-q10/art-20362602
https://www.mdpi.com/2076-3921/13/5/530